Greensboro Pathology, LLC
Greensboro Pathology, LLC was paid $2.16M by Medicaid between Jan 2018 and Dec 2024, across 27 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 60% of everything it billed.
33Billing provider infoGREENSBORO PATHOLOGY, LLC
GREENSBORO, NC 27408
GREENSBORO, NC 27408
33aNPI1023084340assigned 02/27/2006
33bProvider typeSpecialist
28Total paid$2.16M
24GClaims86,082
24DCodes billed27
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in North Carolina
Rank by total paid#23 of 172
Median peer was paid$83K
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official GRATTENDICK, MICHAEL controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,276 | $484K | |
| 2019 | 15,452 | $408K | |
| 2020 | 12,650 | $358K | |
| 2021 | 13,275 | $239K | |
| 2022 | 13,303 | $197K | |
| 2023 | 8,812 | $242K | |
| 2024incomplete | 5,314 | $235K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 60% | 47,373 | 33,914 | $1.30M |
| 88307 | 10% | 6,273 | 4,204 | $225K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 5.0% | 5,867 | 4,284 | $108K |
| 88312 | 3.9% | 2,294 | 1,721 | $85K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.8% | 4,396 | 3,249 | $82K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.8% | 4,265 | 3,228 | $82K |
| 88141 | 1.9% | 3,340 | 2,457 | $42K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.8% | 419 | 341 | $39K |
| 88142 | 1.8% | 3,011 | 2,181 | $38K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1.4% | 1,706 | 1,273 | $30K |
| 88342 | 1.1% | 1,106 | 793 | $24K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.1% | 1,706 | 1,278 | $24K |
15 more codes
| 87653 | <1% | 741 | $17K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 568 | $16K |
| 88304 | <1% | 904 | $11K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 133 | $11K |
| 87481 | <1% | 591 | $9K | |
| 87511 | <1% | 328 | $6K | |
| 88341 | <1% | 114 | $4K | |
| 87081 | <1% | 720 | $4K | |
| 88112 | <1% | 95 | $2K | |
| 85060 | <1% | 31 | $267.54 | |
| 87529 | <1% | 39 | $198.00 | |
| 87210 | <1% | 17 | $65.80 | |
| 88300 | <1% | 15 | $44.60 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 12 | $25.00 |
| 88302 | <1% | 18 | $10.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGRATTENDICK, MICHAEL (VICE PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Laboratory Medicine Consultants LTD | Las Vegas, NV | $9.16M |
| Pathology Solutions LLC | Eatontown, NJ | $5.39M |
| Laboratory of Dermatopathology Adx, LLC | Woodbury, NY | $3.57M |
| Cascade Pathology Services, Corp | Portland, OR | $2.52M |
| Laboratory Medicine Consultants LTD | Las Vegas, NV | $2.33M |
| Consultants in Laboratory Medicine of Greater Toledo | Toledo, OH | $2.28M |
| Mark and Kambour MD PA | Miami Lakes, FL | $776K |
| Dermpath New England, LLC | Boston, MA | $643K |
| Western Pathology Consultants, LTD | Reno, NV | $554K |
| Seacoast Pathology, INC. | Exeter, NH | $392K |
| Hallmark Pathology, P.C. | Melrose, MA | $118K |
| Richard Bernert, LLC | Scottsdale, AZ | $23K |
| Mid-Atlantic Pathology Services, INC. | Sterling, VA | $13K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.